Epigenetic modulation of Reelin function in schizophrenia and bipolar disorder

Reelin Glycoprotein: Structure, Biology and Roles in Health and Disease

Volumn , Issue , 2008, Pages 365-384

  Abdolmaleky, Hamid Mostafavi ^a,b,c,d   Smith, Cassandra L ^a   Zhou, Jin Rong ^b   Thiagalingam, Sam ^c  

^a Boston University   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84920017150     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-76761-1_24     Document Type: Chapter

References (74)

1. Abdolmaleky, H. M., Smith, C. L., Faraone, S. V., Shafa, R., Stone, W., Glatt, S. J., and Tsuang, M. T. (2004a). Methylomics in psychiatry: modulation of gene-environment interactions may be through DNA methylation. Am. J. Med. Genet. 127B(1):51-59.
2. Abdolmaleky, H. M., Faraone, S. V., Glatt, S. J., and Tsuang, M. T. (2004b). Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophr. Res. 67(1):53-62.
3. Abdolmaleky, H. M., Cheng, H. H., Russo, A., Smith, C. L., Faraone, S. V., Shafa, R., Wilcox, M., Glatt, S., Stone, W. S., Nguyen, G., Ponte, J. F., Thiagalingam, S., and Tsuang, M. (2005). Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: A preliminary report. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134B:60-66.
4. Abdolmaleky, H. M., Cheng, K. H., Faraone, S. V., Wilcox, M., Glatt, S. J., Gao, F., Smith, C. L., Shafa, R., Aeali, B., Carnevale, J., Pan, H., Papageorgis, P., Ponte, J. F., Sivaraman, V., Tsuang, M. T., and Thiagalingam, S. (2006). Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 15(21):3132-3145.
5. Abdolmaleky, H. M., Smith, C. L., Zhou, R. J., Thiagalingam, S. (2008). "Epigenetic alterations of the dopaminergic system in major psychiatric disorders" in Pharmacogenomics in drug discovery and development, Yan, Q., Humana Press. London, U.K. 187-212.
6. Akahane, A., Kunugi, H., Tanaka, H., and Nanko, S. (2002). Association analysis of polymorphic CGG repeat in 5′?UTR of the reelin and VLDLR genes with schizophrenia. Schizophr. Res. 58(1):37-41.
7. Akbarian, S. (2003). The neurobiology of Rett syndrome. Neuroscientist. 9(1):57-63.
8. Akbarian, S., Jiang, Y., and Laforet, G. (2006). The molecular pathology of Rett syndrome: Synopsis and update. Neuromol. Med. 8(4):485-494.
9. Ballmaier, M., Zoli, M., Leo, G., Agnati, L. F., and Spano, P. (2002). Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: An emerging animal-based model of schizophrenia. Eur. J. Neurosci. 15(7):1197-1205.
10. Beffert, U., Weeber, E. J., Durudas, A., Qiu, S., Masiulis, I., Sweatt, J. D., Li, W. P., Adelmann, G., Frotscher, M., Hammer, R. E., and Herz, J. (2005). Modulation of synaptic plasticity and memory by reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron 47(4):567-579.
11. Beffert, U., Durudas, A., Weeber, E. J., Stolt, P. C., Giehl, K. M., Sweatt, J. D., Hammer, R. E., and Herz, J. (2006). Functional dissection of reelin signaling by site-directed disruption of disabled-1 adaptor binding to apolipoprotein E receptor 2: distinct roles in development and synaptic plasticity. J. Neurosci. 26(7):2041-2052.
12. Bertino, L., Ruffini, M. C., Copani, A., Bruno, V., Raciti, G., Cambria, A., and Nicoletti, F. (1996). Growth conditions influence DNA methylation in cultured cerebellar granule cells. Dev. Brain Res. 95:38-43.
13. Bestor, T. H. (2000). The DNA methyltransferases of mammals. Hum. Mol. Genet. 9:2395-2402.
14. Bird, A. (2002). DNA methylation patterns and epigenetic memory. Genes Dev. 16:6-21.
15. Bleich, S., Lenz, B., Ziegenbein, M., Beutler, S., Frieling, H., Kornhuber, J., and Bonsch, D. (2006). Epigenetic DNA hypermethylation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence. Alcohol. Clin. Exp. Res. 30:587-591.
16. Bonsch, D., Lenz, B., Kornhuber, J., and Bleich, S. (2005). DNA hypermethylation of the alpha synuclein promoter in patients with alcoholism. Neuroreport 16:167-170.
17. Chan, M. W., Chu, E. S., To, K. F., and Leung, W. K. (2004). Quantitative detection of methylated SOCS-1, a tumor suppressor gene, by a modified protocol of quantitative real time methylation- Specific PCR using SYBR green and its use in early gastric cancer detection. Biotechnol. Lett. 26:1289-1293.
18. Chen, Y., Sharma, R. P., Costa, R. H., Costa, E., and Grayson, D. R. (2002). On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res. 30:2930-2939.
19. Chen, Y., Beffert, U., Ertunc, M., Tang, T. S., Kavalali, E. T., Bezprozvanny, I., and Herz, J. (2005). Reelin modulates NMDA receptor activity in cortical neurons. J. Neurosci. 25(36):8209-8216.
20. Cooney, C. A., Dave, A. A., and Wolff, G. L. (2002). Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J. Nutr. 132:2393-2400S.
21. Costa, E., Davis, J., Grayson, D. R., Guidotti, A., Pappas, G. D., and Pesold, C. (2001). Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol. Dis. 8:723-742.
22. Costa, E., Dong, E., Grayson, D. R., Ruzicka, W. B., Simonini, M. V., Veldic, M., and Guidotti, A. (2006). Epigenetic targets in GABAergic neurons to treat schizophrenia. Adv. Pharmacol. 54:95-117.
23. Costello, J. F., and Plass, C. (2001). Methylation matters. J. Med. Genet. 38(5):285-303.
24. Davies, R., and Morris, B. (1997). Molecular Biology of Neuron. Oxford University Press, London.
25. Dong, E., Agis-Balboa, R. C., Simonini, M. V., Grayson, D. R., Costa, E., and Guidotti, A. (2005). Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionineinduced mouse model of schizophrenia. Proc. Natl. Acad. Sci. USA 102(35):12578-12583.
26. Eastwood, S. L., and Harrison, P. J. (2003). Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: Towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis. Mol. Psychiatry 8(9):769, 821-831.
27. Fackler, M. J., McVeigh, M., Mehrotra, J., Blum, M. A., Lange, J., Lapides, A., Garrett, E., Argani, P., and Sukumar, S. (2004). Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res. 64:4442-4452.
28. Fatemi, S. H., Earle, J. A., and McMenomy, T. (2000). Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol. Psychiatry 5:654-663.
29. Fatemi, S. H., Stary, J. M., Araghi-Niknam, M., and Egan, E. (2005a). GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of reelin and GAD 65 & 67 kDa proteins in cerebellum. Schizophr. Res. 72:109-122.
30. Fatemi, S. H., Snow, A. V., Stary, J. M., Araghi-Niknam, M., Reutiman, T. J., Lee, S., Brooks, A. I., and Pearce, D.A. (2005b). Reelin signaling is impaired in autism. Biol. Psychiatry 57:777-787.
31. Fatemi, S. H., Reutiman, T. J., Folsom, T. D., Bell, C., Nos, L., Fried, P., Pearce, D. A., Singh, S., Siderovski, D. P., Willard, F. S., and Fukuda, M. (2006). Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique. Neuropsychopharmacology 31(9):1888-1899.
32. Fenech, M. (2001). The role of folic acid and vitamin B12 in genomic stability of human cells. Mutat. Res. 475:57-67.
33. Frommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W., Molloy, P. L., and Paul, C. L. (1992). A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 89(5):1827-1831.
34. Goldberger, C., Gourion, D., Leroy, S., Schurhoff, F., Bourdel, M. C., Leboyer, M., and Krebs, M. O. (2005). Population-based and family-based association study of 5′UTR polymorphism of the reelin gene and schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 137(1):51-55.
35. Grayson, D. R., Jia, X., Chen, Y., Sharma, R. P., Mitchell, C. P., Guidotti, A., and Costa, E. (2005). Reelin promoter hypermethylation in schizophrenia. Proc. Natl. Acad. Sci. USA 102(26):9341-9346.
36. Guidotti, A., Auta, J., Davis, J. M., Di-Giorgi-Gerevini, V., Dwivedi, Y., Grayson, D. R., Impagnatiello, F., Pandey, G., Pesold, C., Sharma, R., Uzunov, D., and Costa, E. (2000). Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study. Arch. Gen. Psychiatry 57(11):1061-1069.
37. Guidotti, A., Ruzicka, W., Grayson, D. R., Veldic, M., Pinna, G., Davis, J. M., and Costa, E. (2007). S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport 18(1):57-60.
38. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. (1996). Methylationspecific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93(18):9821-9826.
39. Homayouni, R., Magdaleno, S., Keshvara, L., Rice, D. S., and Curran, T. (2003). Interaction of disabled-1 and the GTPase activating protein Dab2IP in mouse brain. Brain Res. Mol. Brain Res. 115(2):121-129.
40. Huang, C. H., and Chen, C. H. (2006). Absence of association of a polymorphic GGC repeat at the 5' untranslated region of the reelin gene with schizophrenia. Psychiatry Res. 142(1):89-92.
41. Impagnatiello, F., Guidotti, A. R., Pesold, C., Dwivedi, Y., Caruncho, H., Pisu, M. G., Uzunov, D. P., Smalheiser, N. R., Davis, J. M., Pandey, G. N., Pappas, G. D., Tueting, P., Sharma, R. P., and Costa, E. (1998). A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl. Acad. Sci. USA 95(26):15718-15723.
42. Iwamoto, K., Bundo, M., Yamada, K., Takao, H., Iwayama-Shigeno, Y., Yoshikawa, T., and Kato, T. (2005). DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J. Neurosci. 25(22):5376-5381.
43. Jiang, Y. H., Bressler, J., and Beaudet, A. L. (2004). Epigenetics and human disease. Annu. Rev. Genomics Hum. Genet. 5:479-510.
44. Kaludov, N. K., and Wolffe, A. P. (2000). MeCP2 driven transcriptional repression in vitro: Selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery. Nucleic Acids Res. 28(9):1921-1928.
45. Kim, G. D., Ni, J., Kelesoglu, N., Roberts, R. J., and Pradhan, S. (2002). Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J. 21(15):4183-4195.
46. Lavorgna, G., Dahary, D., Lehner, B., Sorek, R., Sanderson, C. M., and Casari, G. (2004). In search of antisense. Trends Biochem. Sci. 29(2):88-94.
47. Levenson, J. M., O'Riordan, K. J., Brown, K. D., Trinh, M. A., Molfese, D. L., and Sweatt, J. D. (2004). Regulation of histone acetylation during memory formation in the hippocampus. J. Biol. Chem. 79(39):40545-40559.
48. Marrone, M. C., Marinelli, S., Biamonte, F., Keller, F., Sgobio, C. A., Ammassari-Teule, M., Bernardi, G., and Mercuri, N. B. (2006). Altered cortico-striatal synaptic plasticity and related behavioural impairments in reeler mice. Eur. J. Neurosci. 24(7):2061-2070.
49. Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., and Sun, Y. E. (2003). DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302(5646):890-893.
50. Martucci, L., Wong, A. H., Trakalo, J., Cate-Carter, T., Wong, G. W., Macciardi, F. M., and Kennedy, J. L. (2003). N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia: TDT and case-control analyses. Am. J. Med. Genet. B Neuropsychiatr. Genet. 119(1):24-27.
51. Monk, M. (1995). Epigenetic programming of differential gene expression in development and evolution. Dev. Genet. 17(3):188-197.
52. Morange, M. (2002). The relations between genetics and epigenetics: A historical point of view. Ann. N.Y. Acad. Sci. 981:50-60.
53. Murphy, B. C., O'Reilly, R. L., and Singh, S. M. (2005). Site-specific cytosine methylation in SCOMT promoter in 31 brain regions with implications for studies involving schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 133(1):37-42.
54. Nishikawa, S., Goto, S., Yamada, K., Hamasaki, T., and Ushio, Y. (2003). Lack of reelin causes malpositioning of nigral dopaminergic neurons: evidence from comparison of normal and Reln(rl) mutant mice. J. Comp. Neurol. 461:166-173.
55. Park-Sarge, O. K., and Sarge, K. D. (1995). Cis-regulatory elements conferring cyclic 3′, 5′-adenosine monophosphate responsiveness of the progesterone receptor gene in transfected rat granulosa cells. Endocrinology 136(12):5430-5437.
56. Persico, A. M., Levitt, P., and Pimenta, A. F. (2006). Polymorphic GGC repeat differentially regulates human reelin gene expression levels. J. Neural Transm. 113(10):1373-1382.
57. Pesold, C., Liu, W. S., Guidotti, A., Costa, E., and Caruncho, H. J. (1999). Cortical bitufted, horizontal, and Martinotti cells preferentially express and secrete reelin into perineuronal nets, nonsynaptically modulating gene expression. Proc. Natl. Acad. Sci. USA 96(6):3217-3222.
58. Petronis, A. (2000). The genes for major psychosis: Aberrant sequence or regulation? Neuropsychopharmacology 23:1-12.
59. Popendikyte, V., Laurinavicius, A., Paterson, A. D., Macciardi, F., Kennedy, J. L., and Petronis, A. (1999). DNA methylation at the putative promoter region of the human dopamine D2 receptor gene. Neuroreport 10(6):1249-1255.
60. Robertson, K. D., and Wolffe, A. P. (2000). DNA methylation in health and disease. Nature Rev. Genet. 1(1):11-19.
61. Russo, V., Martienssen, R., and Riggs, A. (1996). Epigenetic Mechanisms of Gene Regulation. Cold Spring Harbor Laboratory Press, Plainview, NY.
62. Ruzicka, W. B., Zhubi, A., Veldic, M., Grayson, D. R., Costa, E., and Guidotti, A. (2007). Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection. Mol. Psychiatry 12(4):385-397.
63. Singh, S. M., Murphy, B., and O'Reilly, R. L. (2003). Involvement of gene-diet/drug interaction in DNA methylation and its contribution to complex diseases: from cancer to schizophrenia. Clin. Genet. 64(6):451-460.
64. Swift-Scanlan, T., Blackford, A., Argani, P., Sukumar, S., and Fackler, M. J. (2006). Two-color quantitative multiplex methylation-specific PCR. Biotechniques 40:210-219.
65. Tamura, Y., Kunugi, H., Ohashi, J., and Hohjoh, H. (2007). Epigenetic aberration of the human REELIN gene in psychiatric disorders. Mol. Psychiatry 12:519.
66. Tasman, A., Key, J., and Lieberman, J. A. (1997). Psychiatry. W. B. Saunders, Philadelphia.
67. Tremolizzo, L., Carboni, G., Ruzicka, W. B., Mitchell, C. P., Sugaya, I., Tueting, P., Sharma, R., Grayson, D. R., Costa, E., and Guidotti, A. (2002). An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc. Natl. Acad. Sci. USA 99(26):17095-17100.
68. Veldic, M., Caruncho, H. J., Liu, W. S., Davis, J., Satta, R., Grayson, D. R., Guidotti, A., and Costa, E. (2004). DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc. Natl. Acad. Sci. USA 101(1):348-353.
69. Veldic, M., Kadriu, B., Maloku, E., Agis-Balboa, R. C., Guidotti, A., Davis, J. M., and Costa, E. (2007). Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr. Res. 91(1-3):51-61.
70. Waterland, R. A., Lin, J. R., Smith, C. A., and Jirtle, R. L. (2006). Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus. Hum. Mol. Genet. 15:705-716.
71. Weaver, I. C., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., Dymov, S., Szyf, M., and Meaney, M. J. (2004). Epigenetic programming by maternal behavior. Nature Neurosci. 8:847-854.
72. Weaver, I. C., Champagne, F. A., Brown, S. E., Dymov, S., Sharma, S., Meaney, M. J., and Szyf, M. (2005). Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: Altering epigenetic marking later in life. J. Neurosci. 25(47):11045-11054.
73. Weinhausel, A., and Haas, O. A. (2001). Evaluation of the fragile X (FRAXA) syndrome with methylation-sensitive PCR. Hum. Genet. 108(6):450-458.
74. Williams, J., McGuffin, P., Nothen, M., and Owen, M. J. (1997). Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia. Lancet 349(9060):1221.